3rd DCT, HYBRID & CENTRALISED CLINICAL TRIALS WORLD CONGRESS 2027 EUROPE
Where Innovation, Collaboration and Human‐Centred Design Meet to Transform Clinical Research
Millennium Hotel and Conference Centre Gloucester London, UK
Day 2 - Friday 26th February 2027
Implementation, Technology & Real‐World Delivery
- Our Past Trials PRINCIPLE and PANORAMIC
- Our Present Trial: ECRAID-Prime (30 mins) (Logistics, Recruitment and consent, Pharmacy)
- Our Future Trial: PREPARED
Bernadette Mundy, Senior Clinical Research Nurse
Emma Harper, Project Manager
Andrew Fairbairn, Clinical Researcher (General Practitioner)
Lucy Cureton, Senior Clinical Trial Manager
Mona Koshkouei, Head of GMP Operations, Principal Pharmacist
Dr Emily Bongard, Head of Operations,
Nuffield Department of Primary Care Health Sciences, University of Oxford
- Lessons learned from real‐world decentralised and hybrid deployments across multiple therapeutic areas and geographies.
- Deviations and variability introduced by remote data sources, including device inconsistencies and patient behaviour.
- Site‐centric approaches to digital workflow integration that reduce burden and improve operational clarity.
- Strategies to ensure patient safety and data integrity in remote and hybrid trial environments.
Moderator:
Panellists:
- How AI can optimise protocol feasibility, reduce patient burden and improve operational predictability.
- Emerging digital biomarkers and remote assessment technologies that expand the scope of measurable endpoints.
- Predictive recruitment and retention models that support more accurate planning and resource allocation.
- Regulatory considerations for AI‐supported decision‐making and the validation of algorithmic outputs.
- Operational models that support multi‐country decentralised studies with consistent quality and oversight.
- Regulatory variability across regions and strategies for harmonising digital processes internationally.
- Technology harmonisation approaches that reduce fragmentation and improve operational efficiency.
- Lessons learned from large‐scale deployments across diverse therapeutic areas.
- Enterprise‐level strategies that embed digital trial capabilities into long‐term R&D planning.
- Frameworks for integrating decentralisation into clinical operations without disrupting existing workflows.
- Capability‐building initiatives that strengthen digital literacy and operational confidence across teams.
- Metrics used to measure digital transformation impact across portfolios.
- Introducing eSource and its role in connecting routine care with clinical research.
- Advancing adoption through the i~HD eSource Scale-up Task Force.
- Applying the eSource Playbook: from site readiness to implementation and scaling.
- Learning from five oncology centres: coordinator experience and evidence to support wider adoption.
Mats Sundgren, Senior Industry Scientific Director & Co-founder, European Institute, i-HD
- Communication strategies that clearly explain digital trial expectations and reduce uncertainty.
- Support models that help patients navigate remote participation challenges with confidence.
- How co‐creation strengthens trust and improves the relevance of digital trial tools.
- Approaches to ensure equitable access to digital platforms across diverse populations.
- AI‐driven automation tools that reduce manual burden and streamline operational processes.
- Intelligent scheduling and remote visit optimisation features that improve trial efficiency.
- How workflow intelligence enhances predictability and reduces operational risk.
- Collaboration models that align technology innovation with sponsor and CRO needs.
- Combining insights from AI‐driven design, digital biomarkers and remote monitoring to shape next‐generation methodologies.
- Aligning biotech agility, CRO global scaling and pharma transformation to build unified operational models.
- Strengthening patient trust through transparent communication and inclusive digital engagement practices.
- Translating unified data platforms, automation and national policy into sustainable digital ecosystems.
Moderator:
Panelists:
Co-located with Patient Centricity & Collaboration World Congress 2027 Europe.
Joint Networking & Exhibit Area.
